Position history for Avoro Capital Advisors LLC's holdings in AVIDITY BIOSCIENCES INC
Avoro Capital Advisors LLC holds 5.5M shares of RNA (AVIDITY BIOSCIENCES INC), worth $393.5M as of 2025-Q4. The position was decreased (-28.6% shares). RNA represents 3.9% of Avoro Capital Advisors LLC's portfolio.
Current Value
$393.5M
Current Shares
5.5M
Total Value Change
+$127.7M
Total Shares Change
-1.1M
Other major holders of RNA: VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 5.5M |
-28.6% |
| $393.5M |
| 3.9% |
| $72.15 |
0 |
| 2025-Q3 | Increased | 7.6M | +8.4% | $333.1M | 4.3% | $42.63 | 63 |
| 2025-Q2 | Decreased | 7.1M | -7.5% | $200.2M | 3.5% | $29.03 | 0 |
| 2025-Q1 | Increased | 7.6M | +1.7% | $225.1M | 3.5% | $31.60 | 58 |
| 2024-Q4 | Increased | 7.5M | +9.1% | $218.1M | 3.1% | $29.18 | 62 |
| 2024-Q3 | Increased | 6.9M | +5.7% | $315.8M | 4.6% | $42.33 | 61 |
| 2024-Q2 | Increased | 6.5M | +11.7% | $265.7M | 3.5% | $40.85 | 64 |